Cargando…
Methyllycaconitine- and scopolamine-induced cognitive dysfunction: differential reversal effect by cognition-enhancing drugs
There is a growing body of evidence pointing to the pivotal role of alpha-7 nicotinic acetylcholine receptor (α7 nAchR) dysfunction in cognitive disorders such as Alzheimer’s disease or schizophrenia. This study was undertaken to establish and characterize an in vivo model for cognitive disorder sec...
Autores principales: | Andriambeloson, Emile, Huyard, Bertrand, Poiraud, Etienne, Wagner, Stéphanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186438/ https://www.ncbi.nlm.nih.gov/pubmed/25505596 http://dx.doi.org/10.1002/prp2.48 |
Ejemplares similares
-
Palonosetron/Methyllycaconitine Deactivate Hippocampal Microglia 1, Inflammasome Assembly and Pyroptosis to Enhance Cognition in a Novel Model of Neuroinflammation
por: Mohamed, Reem A., et al.
Publicado: (2021) -
Vertigoheel promotes rodent cognitive performance in multiple memory tests
por: Ott, Kerstin, et al.
Publicado: (2023) -
Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
por: Xu, Yu-Min, et al.
Publicado: (2019) -
Apigenin Ameliorates Scopolamine-Induced Cognitive Dysfunction and Neuronal Damage in Mice
por: Kim, Yeojin, et al.
Publicado: (2021) -
Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
por: Wang, Qing, et al.
Publicado: (2023)